Incannex Healthcare (IXHL) Change in Accured Expenses (2023 - 2026)
Incannex Healthcare's (IXHL) quarterly Change in Accured Expenses came in at $458000.0 in Q1 2026, down 68.44% year-on-year from $1.5 million in Q1 2025, and up 940.91% quarter-over-quarter from $44000.0 in Q4 2025.
Incannex Healthcare (IXHL) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Change in Accured Expenses across 4 years of filings, most recently posting $458000.0 for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $458000.0, down 68.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 223.79% YoY), and the FY2025 annual result was $1.4 million, down 54.18% from the prior year.
- Change in Accured Expenses came in at $458000.0 for Q1 2026 at Incannex Healthcare, up from $44000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $3.3 million in Q3 2024 to a low of -$5.4 million in Q3 2025.
- The 4-year median for Change in Accured Expenses is $458000.0 (2026), against an average of -$44181.8.
- Peak annual rise in Change in Accured Expenses reached 955.04% in 2024, while the deepest fall reached 567.79% in 2024.
- Incannex Healthcare's Change in Accured Expenses stood at $891000.0 in 2023, then slumped by 567.79% to -$4.2 million in 2024, then surged by 101.06% to $44000.0 in 2025, then surged by 940.91% to $458000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $458000.0 (Q1 2026), $44000.0 (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458,000.00 |
| Mar 31, 2026 | 458,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | -5.40 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Jun 30, 2025 | 793,000.00 |
| Jun 30, 2025 | 793,000.00 |
| Mar 31, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | -4.17 Mn |
| Dec 31, 2024 | -4.17 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 2.72 Mn |
| Jun 30, 2024 | 2.72 Mn |
| Mar 31, 2024 | -202,000.00 |
| Mar 31, 2024 | -202,000.00 |
| Dec 31, 2023 | 891,000.00 |
| Dec 31, 2023 | 891,000.00 |